History
Selenium (Se) is an essential trace element for humans and all
other animals. The paradox of selenium, however, is that it is
both essential and also toxic (Spallholz, 1994). Selenium deficiency
is responsible for disorders such as "white muscle disease" in
several animal species and Keshan disease, a cardiomyopathy affecting
primarily young women and children in China (Oldfield, 1987;Yang
et al., 1983). Toxic levels of selenium in animals are responsible
for "blind staggers", a CNS disorder in livestock. Since the discovery
of selenium in 1817 it was understood only as a toxic element until
1957, when Klaus Schwarz revealed the ability of selenium to protect
against dietary liver necrosis. It is now known that an average
adult human male requires approximately 40 ug Se/day to make the
25 known human selenium proteins. In 1989 the USDA established
a recommended daily allowance for selenium of 70 ug Se/day for
adult males, 55 ug Se/day for adult females, and many individuals
may ingest up
to 600 ug Se/day or more as nutritional supplements. The UTL, upper
tolerable limit, for selenium is greater than 800 ug Se/day, and
some studies have reported patients taking up to 3.2 mgs of selenium
per day for a year with no serious toxicity. In fulfilling the
nutritional requirement, dietary selenium from the inorganic salts,
selenate and selenite, and the organic selenium compounds, mainly
the primary protein amino acid selenomethionine, are metabolized
by cells into the selenocysteine found in all selenium enzymes
and proteins (Hawkes et al., 1985).
Redox Chemistry
Very recently, an understanding of selenium as
a catalytic generator of superoxide (O2-.) from the oxidation of
thiols has emerged. The catalytic attribute of selenium has been
known for nearly five decades, but the pro-oxidative characteristics
of several selenium compounds has only recently been elucidated.
In general, selenite and selenium dioxide are catalytic by their
oxidation of thiols, such as glutathione (GSH), forming the glutathione
selenopersufide
anion, GSSe- that oxidizes GSH producing superoxide. Diselenides,
such as selenocystine, are reduced by thiols forming the selenide
anion, RSe-, which is also catalytic. The selenide anion is the
catalytic species, catalyzing the oxidation of thiols producing
superoxide, hydrogen peroxide (H2O2) and a putative thiyl radical.
These and likely other reactive oxygen species appear to account
for selenium’s toxicity to cells. The selenide anion
in these small organoselenium compounds, which produces O2-, is
also the catalytic moiety of the selenocysteine residue in all
known selenium enzymes (Spallholz, 1994). This selenium free radical
generating chemistry is shown below:
R-Se- + 2 GSH + O2 —› R-Se-
+ GSSG + O2-.
Covalent Linkage
Unlike other biocidal agents like copper and silver ions
which can also generates reactive oxygen species, selenium can
be covalently attached to various materials with no loss of its
catalytic activity. Selenium can be covalently substituted for
sulfur, oxygen, and
nitrogen in most organic molecules. It may also be covalently attached
to any terminal carbon atom of any molecule forming a catalytic
selenide anion. Using standard and variations of typical protein
and carbohydrate attachment chemistries, carboxyl and amino containing
selenides may be routinely attached to many polymers, peptides,
antibodies, steroids and drugs. Polymers and other molecules with
attached selenides generate superoxide in a dose dependent manner
in biological solutions, in cells or attached to insoluble matrixes
such as silicones.
Because of the benefits of selenium we are
applying the SeLECT technology to a wide range of applications
ranging from armed therapeutics to coatings for medical devices,
industry, and consumer products.
Therapeutics
Selenium compounds may be used as an arming agent for antibodies,
peptides, small molecules, and nucleotides (e.g. aptamers). The
selenium technology attached to a targeting agent delivers a lethal
payload to tumor cells, pathogenic microbes, or other specific
cells. Because of selenium’s unique mode of action, selenium-armed
agents have been shown to kill bacteria at 4o C, indicating that
there need not be metabolic activity for selenium to be effective.
Selenium-armed molecules have even been shown to directly oxidize
virus particles. Due
to the limited localization of the free radical production, bystander
cells are not damaged and the selenium is metabolized without adverse
effects. In fact, a therapeutic dose of selenium is half of the
recommended daily allowance and several-fold less than the amount
taken by many as a
nutritional supplement.
|
| |
Most cancer therapies, such as chemotherapy
and radiation, are intrinsically toxic and can be lethal
to both healthy and diseased cells. While antibodies are
very specific in the cells they target, they also have
several drawbacks. If an antibody does not directly block
signal transmission, then its effectiveness depends on
activating other components of the immune system, delivering
toxic drugs which must be internalized by the cell, or
delivering a dose of radiation
( See Chart ). |
SeLECT armed antibodies overcome most
of the potency obstacles pack the punch of a radiolabeled
antibody without the hepatic or renal toxicity. Internalization
of the antibody is not required since the free radical
reaction is lethal to the targeted cells even at the
cell surface and specific binding is not required. If
the SeLECT antibody binds, the cell will be killed. |
Free radicals are extremely
reactive and typically only travel a very short distance before finding something
to react with. This extreme localization of the toxic effects means that SeLECT
antibodies are very safe for nontargeted bystander cells. |
|
|
| |
|
| |
Lethal |
Specific |
Side Effects Profile |
Cytotoxic Drug |
A |
D |
F |
Blocking Ab |
C |
A |
A |
Immune recruiting Ab |
C |
A |
A |
Drug armed Ab |
B- |
A |
B |
Isotope armed Ab |
A |
B |
C |
SeLECT Ab |
A |
A |
A |
|
|
|
In vitro and in vivo results have demonstrated the effectiveness of selenium
with various targeting agents. Of particular note are results achieved
in a nude mouse colorectal tumor model. All mice received treatment
with an antibody targeting the colorectal tumor cells. One group,
however, received this antibody armed with selenium; the other
group received unarmed antibody. The figure shows the dramatic
effect of utilizing selenium as an arming agent with this antibody.
Colorectal tumor model: the effect of arming with selenium.
| |
 |
 |
|
| |
Antibody With Selenium
|
Antibody Without Selenium
|
|
Coatings
Because selenides can be covalently attached without loss of catalytic
activity, it is particularly well suited for applications requiring
a biocidal surface coating agent.We are investigating and developing
use of selenium coatings for applications including medical devices,
textiles, paints and sealants, consumer products (e.g. sponges),
and other industrial/consumer uses and products. Materials to which
selenium has been already successfully attached include cellulose
sponges, silicone hydrogel lenses, polymethymethacrylate (PMMA,
using a CO2 plasma generator), epoxy, as well as biological molecules
such as
peptides
and antibodies.
| |
 |
 |
|
| |
1) Surface is treated with Selenium
|
2) When bacteria attempt to colonize the coated
surface….
|
|
| |
 |
 |
|
| |
3) Selenium kills the bacteria on contact
|
4) Bacteria can’t live on the Selenium
coated surface
|
|
As a demonstration of the ability of selenium-coated materials in inhibiting
bacterial cell growth, selenium-coated and control sponges were
tested against the ability of the pathogenic bacteria Staphylococcus
aureus to colonize and form a biofilm. Selenium-coated and control
sponges were
immersed in L-broth and inoculated with Staphylococcus
aureus which was allowed to proliferate in the broth for 4 days.
At this time sponges were fixed in gluteraldehyde and visually
examined using a scanning electron microscope following gold sputtering.
The figures
below show electron micrographs (EM) from the selenium-coated sponge
and untreated control sponge at 700 X magnification. The inset
photo on the right shows the untreated sponge at 3000 X magnification.
In the EM of the selenium-coated sponge one can easily see the
cellulose fibers of the sponge. In the untreated control sponge
the entire sponge
is obscured by a Staphylococcus biofilm. In the
inset photo one can see the bacterial cells in the untreated sponge.
Cellulose sponges: antibacterial effect of coating with selenium.
| |
 |
 |
|
| |
Selenium-treated Sponge
|
Untreated Control
|
|
|